Sun F

ORCID: 0000-0003-4334-6805 · 55 papers in corpus
case-report 2024
AME case reports ·doi:10.21037/acr-24-143

BACKGROUND: Uterine cystic adenomyosis (CA) is a unique form of adenomyosis with a single or fused lumen of the cystic space exceeding a diameter of 1 cm that typically results in progressively worsening dysmenorrhea. In most cases, the pro…

observational 2023
Obstetrics and gynecology ·doi:10.1097/aog.0000000000005049

OBJECTIVE: To evaluate the relationship between hysterectomy with and without ovarian conservation and the onset of ovarian failure using anti-müllerian hormone (AMH) levels and imputed final menstrual period (FMP). METHODS: A total of 1,4…

observational 2023
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi ·doi:10.3760/cma.j.cn112338-20221223-01079

Objective: To construct a cervical cancer risk prediction model based on nested case-control study design and Yinzhou Health Information Platform in Ningbo, and provide reliable reference for self-risk assessment of cervical cancer in local…

other 2023
Cellular and molecular life sciences : CMLS ·doi:10.1007/s00018-023-04732-9
observational 2023
·doi:10.21203/rs.3.rs-2752816/v1

AbstractAdenomyosis (AM) is a common gynecological condition that can be classified into different subtypes. This study aimed to evaluate the clinical characteristics, factors and treatment effect in women who diagnosed with intrinsic or ex…

lab-animal 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01208-w

Endometriosis is a common gynecological disorder characterized by the presence of the endometrial glands and the stroma outside the uterine cavity. The disease affects reproductive function and quality of life in women of reproductive age. …

observational 2023
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2023.03.001

STUDY OBJECTIVE: To identify the clinical risk factors for symptomatic recurrence of adenomyosis after laparoscopic adenomyomectomy with a three-year follow-up. DESIGN: Retrospective study. SETTING: University-affiliated hospital. PATIEN…

rct 2023
BMC medicine ·doi:10.1186/s12916-023-02834-6

BACKGROUND: Gonadotropin-releasing hormone (GnRH) antagonists are a promising therapeutic approach for treating hormone-dependent prostate cancer. Currently, the mainstream GnRH antagonists are polypeptide agents administered through subcut…

lab-animal 2022
Cellular and molecular life sciences : CMLS ·doi:10.1007/s00018-022-04637-z

Ovarian endometriosis is a common gynecological condition that can cause infertility in women of childbearing age. However, the pathogenesis is still unknown. We demonstrate that the carboxyl terminus of Hsc70-interacting protein (CHIP) is …

meta-analysis 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.918331

OBJECTIVE: This study systematically evaluated the effectiveness and safety of therapeutic vaccines for precancerous cervical lesions, providing evidence for future research. METHODS: We systematically searched the literature in 10 databas…

lab-animal 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.938123

OBJECTIVE: Our previous work found COX4I2 was associated with angiogenesis in pheochromocytoma. The purpose of this study was to explore the role of COX4I2 in regulating angiogenesis in pheochromocytoma. METHODS: Distribution of COX4I2 was…

observational 2022
·doi:10.21203/rs.3.rs-2029690/v1

Abstract Background: Laparoscopic adenomyomectomy combined with intraoperative placement of levonorgestrel-releasing intrauterine device (LNG-IUS) is a novel conservative surgical procedure for adenomyosis. Our study aimed to compare the e…

observational 2022
Women's health reports (New Rochelle, N.Y.) ·doi:10.1089/whr.2022.0080

BackgroundThe optimal protocol for minimal stimulation in vitro fertilization (IVF) has yet to be established. This study aims to determine if the use of gonadotropin-releasing hormone (GnRH) antagonist during minimal stimulation improves o…

lab-animal 2022
International journal of molecular sciences ·doi:10.3390/ijms23020943

Pregnancy loss (PL) is one of the common complications that women can experience during pregnancy, with an occurrence rate of 1 to 5%. The potential causes of pregnancy loss are unclear, with no effective treatment modalities being availabl…

other 2021
Panminerva medica ·doi:10.23736/s0031-0808.21.04463-3
observational 2021
Translational andrology and urology ·doi:10.21037/tau-21-229

BACKGROUND: Previous study has been reported that COX4I2 expression level demonstrated a positive correlation with microvessel density in pheochromocytomas (PCC) samples, suggesting that the expression of COX4I2 maybe related to blood suppl…

diagnostic-accuracy 2021
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2021.11.019

RESEARCH QUESTION: Could extracellular vesicle-derived long non-coding RNA (lncRNA) serve as promising circulating biomarkers for endometriosis? DESIGN: To obtain novel diagnostic markers, 85 patients with endometriosis were enrolled as th…

lab-animal 2021
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2021.710407

Adenomyosis (AM) is a disease in which endometrial tissue invades the myometrium and has a 10-60% prevalence in reproductive-aged women. TSC2 regulates autophagy via mTOR1 signalling in colorectal cancer and endometrial carcinoma. Dysregula…

other 2021
Frontiers in molecular biosciences ·doi:10.3389/fmolb.2021.656145

Endometriosis (EM) is a chronic neuroinflammatory disorder that is associated with pain and infertility that affects ∼10% of reproductive-age women. The pathophysiology and etiology of EM remain poorly understood, and diagnostic delays are …

observational 2021
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00513-6

Adenomyosis is associated with dysmenorrhea, infertility, and lesional fibrosis. The pathogenesis of adenomyosis is still unclear. Plasminogen activator inhibitor 1 (PAI-1) plays important roles in pathological activities like tumor metasta…

review 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.800327

There is emerging evidence that environmental toxicants, in particular endocrine disrupting chemicals (EDCs) such as cadmium and perfluorooctanesulfonate (PFOS), induce Sertoli cell and testis injury, thereby perturbing spermatogenesis in h…

lab-animal 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00690-0

BACKGROUND: The denomyotic junctional zone (JZ) plays an important role in the pathogenesis of adenomyosis. Proliferating cell nuclear antigen (PCNA) is an important nuclear marker of cell proliferation. This study aimed to evaluate the eff…

observational 2020
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgz012

CONTEXT: The relationship between reproductive and cardiometabolic aging is unclear. It is unknown if the relationship differs across different clinical populations. OBJECTIVE: To determine whether markers of ovarian reserve are associated…

observational 2020
F&S reports ·doi:10.1016/j.xfre.2020.05.010

OBJECTIVE: To evaluate the quantity and use of embryos cryopreserved at assisted reproductive technology (ART) clinics in the United States from 2004 through 2013 and to characterize trends in ART cycles in which all embryos were cryopreser…

other 2020
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14571

AIM: To evaluate the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative replacement of levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of symptomatic adenomyosis. METHODS: This…